- Company
- Tests & Reagents
- Overview
- CE-IVD Tests
- affigene CE-IVD Products
- affigene DNA Extraction Kit
- Cepheid microRNA
- Industrial Reagents
- Biothreat Tests
- Literature
- Request Information
- Systems & Software
- Resources & Support
- Investors
- Product Catalog
Xpert CT/NG
90 minute detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).
“For the first time, we are able to offer highly accurate results we can act upon while the patient is still in the clinic. This may have far-reaching effects, such as improving contact tracing and reducing ongoing spread of infection in the community, as well as being popular with our patients. I am impressed with the highly accurate results obtained with Xpert® CT/NG. The simplicity of sample prep and the easy-to-use format of the GeneXpert® cartridge provide same-day results in around 90 minutes.” - Dr. Simon Goldenberg, Consultant Microbiologist, Guy’s & St. Thomas’ NHS Foundation Trust, London
Runs On: GeneXpert® System
Runs On: GeneXpert® System
The Need
According to the World Health Organization (2001), an estimated 92 million chlamydia infections occurred worldwide, affecting more than 50 million women and 42 million men. These numbers are followed closely by a staggering 62 million cases of gonorrhoeae, ranging in numbers from 1 to 3.5 million in West and Eastern Europe, to an alarming 27 million in South and Southeast Asia.
Young people under 25 years of age carry the burden of up to 50% of CT/NG infections in a population. Infections left undiagnosed and treated impact patient health, fertility, and increase vulnerability to other opportunistic infections such as HPV and HIV.
N. gonorrhoeae drug resisitance has evolved in the last 100 years from increased penicillin resistance to fluroquinalone resistance, making the need to test and effectively treat infections a critical concern to public health. Since in many countries, incidence or prevalence data are not complete enough to provide an accurate picture of disease distribution, the significant proportion of asymptomatic and undiagnosed infections limits healthcare providers the ability to contain the spread of the disease.
The Solution
Xpert® CT/NG
- Simultaneous detection of both CT and a dual target NG
- Sample adequacy and Process controls for every sample tested
- Results in 90 minutes; requires no instrumentation other than the GeneXpert® System
- On-demand results enable physicians to consult and treat patients with the appropriate medications